Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,862.11

-2.52 (-0.14%)

, KR

Kroger

$25.78

0.22 (0.86%)

19:17
04/21/19
04/21
19:17
04/21/19
19:17

Fly Intel: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. E-commerce is transforming the grocery business, forcing cash-strapped companies to overhaul their operations and invest heavily in technology and talent to keep customers from straying to Amazon (AMZN), while having to keep food prices low, The Wall Street Journal's Heather Haddon reported. The transition has proven rough for Kroger (KR), which stayed focused on store sales long after mass-merchant competitors were investing in online-ordering technology and delivery services, the publication noted. Further, sales at Kroger have grown more slowly than at Walmart (WMT) and Target (TGT), which have more robust online operations, Haddon said, adding that Kroger has now turned to acquisitions to boost its digital reach. 2. As Tesla (TSLA) faces questions about whether demand for the Model 3 compact car is slowing, CEO Elon Musk wants investors to focus on vehicles driving themselves in a robot-taxi fleet, The Wall Street Journal's Tim Higgins reported. Musk is gathering investors Monday to reveal the electric car maker's latest efforts to develop self-driving car technology and his strategy for deploying it, just two days before Tesla reports quarterly financial results, which are expected to show a loss on slumping vehicle sales, the publication added. 3. Investing in health insurers today amounts to a bet against the Medicare for All proposal championed by Senator Bernie Sanders and other Democrats running for president, Andrew Bary wrote in this week's edition of Barron's. While the stocks have been battered, given the long odds of an industry-killing plan becoming law, shares of the leading insurers - UnitedHealth (UNH), Anthem (ANTM), Cigna (CI), Humana (HUM) and CVS (CVS) - look appealing, Bary contended. The stocks trade for an average of just 12 times projected 2019 earnings and UnitedHealth, Anthem, and Humana already are generating double-digit growth in earnings per share, he added. 4. AT&T (T) subsidiary Warner Bros' "The Curse of La Llorona" opened ahead of expectations with $26.5M to easily win the weekend. This was, however, the worst Easter at the domestic box office in 14 years as Hollywood studios held back releasing bigger event pics. Overseas, "The Curse of La Llorona" took in $30M from 71 markets for a global bow of $56.4M. The movie sports a B- CinemaScore and a 32% Rotten Tomatoes score. 5. Spotify (SPOT), Boston Beer (SAM) and Pinterest (PINS) were mentioned cautiously in this week's edition of Barron's.

AMZN

Amazon.com

$1,862.11

-2.52 (-0.14%)

KR

Kroger

$25.78

0.22 (0.86%)

WMT

Walmart

$103.15

0.02 (0.02%)

TGT

Target

$83.23

0.51 (0.62%)

TSLA

Tesla

$273.25

2.13 (0.79%)

UNH

UnitedHealth

$221.74

4.93 (2.27%)

ANTM

Anthem

$239.63

3.38 (1.43%)

CI

Cigna

$148.95

3.46 (2.38%)

HUM

Humana

$240.65

7.645 (3.28%)

CVS

CVS Health

$52.62

0.08 (0.15%)

T

AT&T

$32.04

0.09 (0.28%)

SPOT

Spotify

$139.53

1.88 (1.37%)

SAM

Boston Beer

$266.90

0.89 (0.33%)

PINS

Pinterest

$24.46

(0.00%)

  • 22

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 29

    Apr

  • 30

    Apr

  • 01

    May

  • 01

    May

  • 02

    May

  • 06

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 10

    May

  • 15

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 18

    May

  • 19

    May

  • 20

    May

  • 22

    May

  • 23

    May

  • 29

    May

  • 03

    Jun

  • 07

    Jun

  • 18

    Jun

  • 13

    Nov

AMZN Amazon.com
$1,862.11

-2.52 (-0.14%)

04/17/19
CHLM
04/17/19
INITIATION
Target $20
CHLM
Buy
Quotient Technology initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Chad Bennett started coverage of Quotient Technology (QUOT) with a Buy rating and a $20 price target. The analyst notes that the company is transitioning from being a provider of digital coupons to offering a robust digital marketing platform. Further, Bennett says that Quotient Technology has as much consumer data as Amazon (AMZN) "that nobody has heard of."
04/15/19
KEYB
04/15/19
NO CHANGE
KEYB
Amazon looks to be testing new apparel initiative, says KeyBanc
KeyBanc analyst Edward Yruma says that Amazon looks to be testing a new apparel initiative called Prime Stylist, which will offer women a curated set of apparel options with the assistance of a personal stylist. This marks an intensification of Amazon's efforts in apparel, which the analyst views as broadly negative for its competitors. Yruma continues to believe that apparel and grocery are two key focus areas within Amazon's retail business given its relatively low market share as well as favorable secular attributes.
04/18/19
MSCO
04/18/19
NO CHANGE
MSCO
Overweight
Morgan Stanley prefers Seagate over Western Digital as cloud capex recovery play
Morgan Stanley analyst Katy Huberty said her industry conversations have increased her confidence in a cloud recovery in the second half. Her checks suggest orders from Microsoft (MSFT) will restart in Q2 and rise to above trend levels in Q3 while orders from Amazon (AMZN), Google (GOOGL), Facebook (FB) and Apple (AAPL) are expected to return in Q3. Given this context, Huberty said she prefers Seagate (STX) over Western Digital (WDC) as a play on a cloud capital expenditure recovery, noting that inventory levels position hard disk drives to benefit before NAND, that HDD pricing is structurally better positioned than NAND and her view that Seagate has a better HDD product portfolio to meet cloud demand in the second half of 2019 and first half of 2020. Huberty has an Overweight rating on Seagate and the firm has an Equal Weight rating on Western Digital, which is covered by analyst Joseph Moore.
04/16/19
BMOC
04/16/19
NO CHANGE
Target $470
BMOC
Outperform
Netflix price target raised to $470 from $440 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Netflix (NFLX) to $470 and kept his Outperform rating ahead of its Q1 earnings today, saying he expects "strong results" from the company. The analyst bases his price target change on his rolled out estimates for 2021-2028 and believes that Netflix still has "room to grow" internationally - particularly in India and Japan - while improving its per subscriber leverage on content spend and generating "steady growth of its consumer product licensing revenues." Salmon also believes that while Netflix remains the clear leader in global streaming, Amazon (AMZN) and Disney (DIS) can also be "long-term winners" in the sector.
KR Kroger
$25.78

0.22 (0.86%)

02/07/19
BUCK
02/07/19
INITIATION
Target $24
BUCK
Underperform
Kroger initiated with an Underperform at Buckingham
Buckingham analyst Bob Summers started Kroger with an Underperform rating and $24 price target. The company has established an "overly ambitious" goal for fiscal 2020 that entails significant investment, Summers tells investors in a research note. The analyst believes deflation, competitive activity, fuel profitability, and the economic cycle pose risk to the company's EBIT growth.
03/21/19
LOOP
03/21/19
NO CHANGE
Target $102
LOOP
Hold
Walmart grocery sales productivity outperforming supermarkets, says Loop Capital
Loop Capital analyst Andrew Wolf kept his Hold rating and $102 price target on Walmart (WMT), saying the company's U.S. grocery comps outperformed the supermarket chains in 2018 as it has since 2016, even though the gap has narrowed. The analyst notes that Kroger (KR) made the biggest strides last year, and that the company was also the best performer in the 2013-2015 period supermarkets last made strong market share gains. Looking ahead, Wolf says the accelerating food-price inflation anticipated by the USDA could also "bode well for continued further same-store sales acceleration for both Walmart and the grocers in 2019."
03/20/19
EVER
03/20/19
INITIATION
Target $27
EVER
In Line
Kroger initiated with an In Line at Evercore ISI
Evercore ISI analyst Michael Montani started Kroger with an In Line rating and $27 base case price target, citing his view that Kroger's efforts to build out its ecosystem are admirable, but it's too soon to expect an "Amazon-esque" flywheel to drive sustainable EBIT growth.
02/08/19
02/08/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. American Airlines (AAL) initiated with a Hold at Argus. 2. Walmart (WMT) and Sprouts Farmers Market (SFM) were initiated with a Neutral at Buckingham, while Kroger (KR) was initiated with an Underperform. 3. Wrap Technologies (WRTC) initiated with a Buy at Chardan. 4. nLight (LASR) initiated with a Hold at Craig-Hallum. 5. RA Pharmaceuticals (RARX) initiated with a Buy at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
WMT Walmart
$103.15

0.02 (0.02%)

04/01/19
SBSH
04/01/19
UPGRADE
Target $18
SBSH
Neutral
Bed Bath & Beyond upgraded to Neutral from Sell at Citi
Citi analyst Geoff Small upgraded Bed Bath & Beyond (BBBY) to Neutral from Sell and raised his price target for the shares to $18 from $10 after taking over coverage of the name. Citi transferred coverage of Broadlines & Hardlines Retail names to Small. The analyst assumed coverage with Buy ratings on AutoZone (AZO), BJ's Wholesale (BJ), Home Depot (HD), Lowe's (LOW), O'Reilly Automotive (ORLY) and Walmart (WMT). The U.S. consumer remains on "solid footing" amid low unemployment, rising wages, declining gas prices, manageable levels of debt, and elevated consumer confidence, Small tells investors in a research note. However, he points out that we are in the ninth year of the current economic expansion and "the possibility of a macroeconomic slowdown cannot be ignored." The analyst prefers retailers operating in "defensive sectors that are less susceptible to disruption by online competitors," namely auto parts, broadlines and home improvement retail. Small also assumed Advance Auto Parts (AAP), Best Buy (BBY), Costco (COST) and Office Depot (ODP) with Neutral ratings.
04/02/19
JEFF
04/02/19
NO CHANGE
Target $76
JEFF
Buy
Green Dot pullback brings good buying opportunity, says Jefferies
Jefferies analyst John Hecht believes the pullback in shares of Green Dot (GDOT) represents a good opportunity to buy the stock. Green Dot trades 25% below its three year average multiple amid "overdone" concerns around the Walmart (WMT) renewal and fears about slowing revenue and account growth, Hecht tells investors in a research note. The analyst says that while the WalMart MoneyCard private label program renewal represents an overhang, he expects Green Dot to keep the program. He considered a scenario with increased commissions for the MoneyCard, and still only sees a "modest" potential impact on earnings. Hecht lowered his price target for Green Dot to $76 from $100 and keeps a Buy rating on the shares.
04/02/19
DBAB
04/02/19
UPGRADE
Target $15
DBAB
Buy
Deutsche Bank upgrades Hostess Brands to Buy, boosts price target to $15
Deutsche Bank analyst Rob Dickerson upgraded Hostess Brands (TWNK) to Buy from Hold and raised his price target for the shares to $15 from $12. Management execution, a turnaround to profitability in the Chicago bakery and improved pricing could return Hostess to "top-tier revenue growth" this year, Dickerson tells investors in a research note. He believes the lapping of the Walmart (WMT) merchandising issues in Q2 and better pricing offsetting higher freight costs and wage inflation should boost the company's results.
04/08/19
PIPR
04/08/19
NO CHANGE
Target $2070
PIPR
Overweight
Piper teen survey shows Amazon Prime adoption 'once again' increased
Piper Jaffray's survey of 8,000 U.S. teens showed improved Amazon mindshare, 50% versus 47% in the fall 2018 survey, and that Prime adoption, "once again," increased, analyst Michael Olson tells investors in a research note. 76% of respondents indicated their family had a Prime membership versus 74% in the fall 2018 survey, says the analyst. This indicates the number of U.S. Prime households would be in the 85M range and growing, albeit at a decelerating rate, adds Olson. He believes this "massive scale is crucial, as it makes it very difficult for competitors, such as Wal-Mart, to change consumer habits." The analyst reiterates an Overweight rating on Amazon.com with a $2,070 price target.
TGT Target
$83.23

0.51 (0.62%)

03/20/19
EVER
03/20/19
INITIATION
Target $80
EVER
In Line
Target initiated with an In Line at Evercore ISI
Evercore ISI analyst Greg Melich initiated Target with an In Line rating and $80 base case price target, stating that in the upper $70s, the risk/reward appears balanced. He believes 2019 extends what will likely prove a multi-year margin investment cycle, Melich tells investors.
03/21/19
GDHS
03/21/19
UPGRADE
GDHS
Buy
Target upgraded to Buy from Accumulate at Gordon Haskett
03/21/19
GDHS
03/21/19
NO CHANGE
GDHS
Gordon Haskett shakes up retailer rankings with six upgrades, three downgrades
Gordon Haskett analysts Chuck Grom, John Park and Andrew Minora have recalibrated their ratings in broadline and hardline retail with the Q4 earnings season nearly complete, stating that holiday results were mixed with clear winners and losers and that year-to-date sales have been "extremely choppy." The firm's latest macro/consumer survey results suggest that some optimism has resurfaced and they see a scenario where there is a release of significant pent-up demand for the retail group. Within the context of a portfolio approach to the space, the analysts upgraded Target (TGT), Tractor Supply (TSCO), Dollar Tree (DLTR), BJ's Wholesale (BJ) to Buy from Accumulate, upgraded Wayfair (W) and Floor & Decor (FND) to Accumulate from Hold, and downgrade Nordstrom (JWN) and Sprouts Farmers Market (SFM) to Reduce from Hold. The analysts also downgraded Pier 1 Imports (PIR) to Underperform from Hold.
04/16/19
04/16/19
UPGRADE
Target $15

Buy
e.l.f. Beauty upgraded to Buy at DA Davidson on increased shelf space presence
As previously reported, DA Davidson analyst Linda Bolton Weiser upgraded e.l.f. Beauty to Buy from Hold and raised her price target to $15 from $7. The analyst cites the findings of her proprietary store checks suggesting that the company products have seen a 17% increase in shelf space at Target (TGT), overtaking Coty's (COTY) Covergirl brand, while its Q1 sales "inflected from down high-single digits" in Q4 to low-single digits. Weiser believes that her FY20 sales forecast of a 2% decline may be conservative based on these findings.
TSLA Tesla
$273.25

2.13 (0.79%)

04/11/19
ROTH
04/11/19
NO CHANGE
Target $240
ROTH
Neutral
Tesla price target lowered to $240 from $270 at Roth Capital
Roth Capital analyst Craig Irwin lowered his price target for Tesla (TSLA) to $240 from $270, while reiterating a Neutral rating on the shares. The analyst believes the direct read on Panasonic (PCRFY)/Tesla suspending plans for Gigafactory expansion is the partners probably do not see Tesla achieving projected sales volumes, and therefore necessary battery demand. The analyst thinks Tesla's battery costs are too high, with METI data pointing to Tesla's cell costs at around $240/kWh, while his checks show VW (VWAGY)/Porsche paying $250/kWh, indicating Tesla has no advantage here. Overall, Irwin believes Tesla's vehicle sales are slow because costs are simply too high for consumers.
04/10/19
04/10/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with a Neutral at Nomura Instinet. 2. Community Healthcare (CHCT) initiated with an Outperform at Baird. 3. Community Bank System (CBU) initiated with an Equal Weight at Stephens. 4. Fox Corp re-initiated with a Market Perform at BMO Capital. 5. Wendy's (WEN) initiated with an Outperform at Cowen. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/16/19
OPCO
04/16/19
NO CHANGE
Target $437
OPCO
Outperform
Tesla's story undergoing yet another 'significant' shift, says Oppenheimer
Oppenheimer analyst Colin Rusch believes Tesla's story is undergoing "yet another significant shift." Beyond Model 3 demand and cost reduction driving operating cash flow, the analyst thinks the Model S and X refresh cycle and pricing strategy are in focus for short-term investors while the longer-term story is increasingly weighted to China sell-through. Important in the Model S transition is that it remains Tesla's highest margin product and provides some cover for lower margins on Model X and Model 3, he contends, adding that any reduced volume on that vehicle will be a headwind for Tesla's margins. Rusch is lowering Model S and X deliveries in his 2019 estimates and lowering margins looking for incremental information on production cadence. He reiterates an Outperform rating and a $437 price target on the shares.
04/18/19
SBSH
04/18/19
NO CHANGE
Target $238
SBSH
Sell
Tesla price target lowered to $238 from $273 at Citi
Citi analyst Itay Michaeli lowered his price target for Tesla after updating his model to reflect the recently reported Q1 deliveries. The analyst maintains a Sell rating on the shares.
UNH UnitedHealth
$221.74

4.93 (2.27%)

04/17/19
JPMS
04/17/19
NO CHANGE
Target $235
JPMS
Neutral
JPMorgan lowers UnitedHealth target to $235 on 'sustainable' political risk
JPMorgan analyst Gary Taylor last night lowered his price target for UnitedHealth to $235 from $301 following the company's Q1 earnings report. The reduction is due to "renewed and sustainable Election year political risk," particularly around leading Democrats' plans for single-payor Medicare-For-All plans, Taylor tells investors in a research note. The analyst, however, does not believe UnitedHealth said anything fundamentally negative on the earnings call to justify the corresponding stock selloff. The analyst attributes the reversal in trading yesterday's to renewed and continuing Medicare-For-All political fears. He keeps an Overweight rating on shares of UnitedHealth. The stock in morning trading is down 3%, or $7.64, to $213.32.
04/17/19
SPHN
04/17/19
NO CHANGE
SPHN
Issues facing healthcare sector now 'modest' compared to 2008-10, says Stephens
Stephens analyst Scott Fidel noted that the managed care group has sharply underperformed the S&P 500 over the last month amid "political rhetoric" around point-of-sale drug rebates and Medicare for all policy proposals, though he believes the issues facing the sector right now "seem modest in comparison" to the "dark days of 2008-2010." While recent Medicare for all proposals have rattled investors, "they will face enormous uphill battles," Fidel tells investors. Hospital stocks have outperformed MCOs year-to-date, but the group declined about 9% yesterday and underperformed the MCO group, which Fidel attributes to acknowledgement by industry bellwether UnitedHealth (UNH) of the significant disruptive nature of Medicare for all, which may have sparked additional fears, as well as one less calendar day being called out by UnitedHealth as benefiting Q1 MLRs and Johnson & Johnson's (JNJ) earnings call commentary on declining sequential hospital admissions from Q4. Publicly traded companies in the hospital space include Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS). Publicly traded companies in the managed care space include Anthem (ANTM), CVS Health (CVS), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
04/18/19
LEER
04/18/19
NO CHANGE
LEER
Medicare-For-All risk overblown, investors should buy MCOs, says SVB Leerink
SVB Leerink analyst Ana Gupte believes Medicare-For-All risk is overblown, not the same as 2008/09, and recommends investors step in now to buy MCOs. The analyst believes it is a "once in a decade opportunity" to get high quality names at these depressed multiples, with UnitedHealth (UNH), Anthem (ANTM), and Humana (HUM) being her favorites.
04/17/19
RBCM
04/17/19
NO CHANGE
Target $83
RBCM
Outperform
eHealth selloff not related to company specific news, says RBC Capital
RBC Capital analyst Frank Morgan says he's found no company specific news that would explain the weakness today in shares of eHealth. Rather, the analyst attributes the 22% pullback to continued selling in managed care operators and providers, which began yesterday morning. He attributes yesterday's sell-off to Democratic presidential candidate rhetoric around Medicare-for-All, including a tweet from candidate Bernie Sanders during UnitedHealth's Q1 earnings call advocating for MFA. Morgan believes investors were looking to take profits in any strong year-to-date performers, like eHealth. The analyst has an Outperform rating on the stock with an $83 price target. eHealth in afternoon trading is down 22%, or $14.05, to $51.38.
ANTM Anthem
$239.63

3.38 (1.43%)

03/28/19
GSCO
03/28/19
NO CHANGE
GSCO
Federal judge blocking Medicaid work rule positive for MCOs, says Goldman Sachs
Goldman Sachs analyst Stephen Tanal noted that Politico reported that a federal judge ruled for the second time to block new work requirements as a condition for Medicaid eligibility in Kentucky and Arkansas, calling the ruling an incremental positive for Managed Care and Provider companies. MCOs whose primary business is Medicaid managed care are most exposed to this theme, said Tanal, who lists Molina (MOH), WellCare (WCG) and Centene (CNC) as three with a higher percentage of MMC lives in states that have submitted waivers requesting approval to impose work requirements. However, the analyst also noted that Kentucky's Governor has already issued an executive order indicating the state would appeal any decision by a court against work requirements and, if unsuccessful, would reverse its Medicaid Expansion program. WellCare, CVS' (CVS) Aetan, Humana (HUM) and Anthem (ANTM) all operate in Kentucky's Medicaid managed care program, the analyst noted.
03/29/19
03/29/19
DOWNGRADE

WellCare downgraded to Hold at Argus on Centene merger
Argus analyst David Toung downgraded WellCare (WCG) to Hold after it agreed to be acquired by Centene (CNC) in a $17.3B deal or at $305.39 per share. The analyst notes that because the deal would yield an entity that is smaller than the insurance industry giants, it may receive a more favorable treatment from the regulators than the failed Aetna (AET) -Humana (HUM) and Anthem (ANTM)-Cigna (CI) deals, but warns that some antitrust scrutiny is still possible due to overlaps between the companies in a few states. Toung adds that the new company would have "strengths in Medicare Advantage and Medicaid, both of which are growing markets."
CI Cigna
$148.95

3.46 (2.38%)

04/05/19
COWN
04/05/19
NO CHANGE
COWN
Centene, Molina could be 'compelling' targets for Humana, says Cowen
Cowen analyst Charles Rhyee said he believes Centene's (CNC) planned takeover of WellCare (WCG) could potentially accelerate Humana's (HUM) timeline to acquire a scaled Medicaid asset, noting that it currently has the second smallest Medicaid book among managed care organizations. His analysis suggests Centene and Molina Healthcare (MOH) could both be "compelling acquisition targets" for Humana and believes the company has the financial capacity to make a bid for either, though Rhyee added that he does not believe Humana needs to rush a decision. Rhyee sees about a one year window in which Humana "can dictate the Medicaid M&A market" before Cigna (CI) and/or CVS Health (CVS) can get involved, he tells investors. While the analyst believes Centene makes the most sense as a potential target for Humana if the latter does not win the Texas STAR+PLUS contract, he suspects Centene is not willing to sell and believes Humana would have to offer a significant premium. If Humana does win the Texas STAR+PLUS contract it does not need to pursue large scale M&A, but a deal could be attractive anyway, Rhyee said.
04/10/19
CANT
04/10/19
NO CHANGE
CANT
Senate hearing a net positive for PBMs, says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper views yesterday's Senate hearing as a net positive for the pharmacy benefit managers. The PBMs represented were Cigna (CI), CVS Health (CVS), UnitedHealth (UNH), Humana (HUM) and Prime Therapeutics. Although the Senators were not supportive of the PBMs, the executives responded well to questions and put forth a solid effort to address concerns regarding their business model and incentives, Halper tells investors in a research note. Overall, he views the hearing as a net positive for PBMs "as the group was able to counter the negative sentiment with constructive responses, recognizing this story is far from over."
HUM Humana
$240.65

7.645 (3.28%)

CVS CVS Health
$52.62

0.08 (0.15%)

04/18/19
PIPR
04/18/19
NO CHANGE
Target $73
PIPR
Overweight
Tabula Rasa weakness brings 'compelling entry point,' says Piper Jaffray
Piper Jaffray analyst Sean Wieland is "incrementally more positive" on Tabula Rasa HealthCare's (TRHC) growth outlook after traveling with the company's CFO Brian Adams. CVS Health (CVS) provides a "strong validation" of Tabula Rasa's value proposition, and multiple opportunities should result in a higher margin product mix, Wieland tells investors in a research note. Further, the analyst believes the recent weakness in the stock has created a "compelling entry point." He reiterates an Overweight rating on Tabula Rasa HealthCare with a $73 price target.
04/17/19
GUGG
04/17/19
INITIATION
GUGG
Buy
CVS Health assumed with a Buy at Guggenheim
Guggenheim analyst Glen Santangelo assumed coverage of CVS Health with a Buy rating and $63 price target, lowered from a previous price target of $85. The analyst is "excited about the strategic repositioning of the company and the long-term opportunities for the new model," but noted that he "underestimated the structural and integration issues facing the business." That said, Santangelo believes that much of the damage to the stock is already done, and believes CVS Health is a good fit for long-term investors that can handle near-term volatility.
04/15/19
04/15/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CVS Health (CVS) downgraded to Perform from Outperform at Oppenheimer with analyst Michael Wiederhorn saying he views it as more of a long-term opportunity given the potential timeline to execute on its strategy and the near-term legacy business challenges. 2. Infosys (INFY) downgraded to Hold from Buy at Deutsche Bank and Investec, to Reduce from Neutral at Nomura Instinet, to Underperform from Neutral at Credit Suisse, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at Citi and BofA/Merrill. 3. Celanese (CE) downgraded to Hold from Buy at Deutsche Bank with analyst David Begleiter saying the company's leadership transition creates uncertainty. 4. Alliance Data (ADS) downgraded to Underweight from Equal Weight at Stephens and to Market Perform from Outperform at BMO Capital. 5. Wells Fargo (WFC) downgraded to Neutral from Conviction Buy at Goldman Sachs, to In Line from Outperform at Evercore ISI, and to Neutral from Buy at BofA/Merrill and Buckingham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
T AT&T
$32.04

0.09 (0.28%)

04/17/19
GSCO
04/17/19
NO CHANGE
GSCO
Sprint, T-Mobile headlines positive for Dish, Intelsat, says Goldman Sachs
Goldman Sachs analyst Brett Feldman, while taking no view on the outcome of the proposed merger between Sprint (S) and T-Mobile (TMUS), laid out his thoughts for other industry participants following the Wall Street Journal's report that the Department of Justice is unlikely to approve the deal as currently structured. The analyst believes investors will initially see the headlines as negative for the other major wireless carriers, namely AT&T (T) and Verizon (VZ), since they "create uncertainty over long-term industry structure." Further, investors will initially see these headlines as a slight positive for tower operators American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC) as they "imply less risk of material cell site decommissioning," Feldman told investors earlier in a research note. The analyst also thinks investors will view the Journal's report as positive for owners of excess spectrum such as Dish (DISH) and Intelsat (I) and a slight positive for cable operators like Altice USA (ATUS), Charter (CHTR) and Comcast (CMCSA).
04/05/19
04/05/19
UPGRADE
Target $36

Outperform
Viacom upgraded to Outperform from Sector Perform at RBC Capital
As previously reported, RBC Capital analyst Steven Cahall upgraded Viacom (VIAB) to Outperform from Sector Perform and raised his price target to $36 from $31, saying the company's "less contentious" than feared DirecTV (T) deal improves its standing and "paves the way toward merger talks" with CBS (CBS). The analyst sees an implied upside for Viacom stock at over 30% on the CBS deal prospects and believes that investors should own both to hedge the exchange ratio risk of the potential transaction.
03/27/19
JPMS
03/27/19
NO CHANGE
JPMS
Fundamentals across cable remain strong, says JPMorgan
Sustained household formation and wage growth, along with a pullback in promotional activity at AT&T (T), the main competitor to most multi-service operators, keeps fundamentals across cable strong, JPMorgan analyst Philip Cusick tells investors in a research note. In 2018, the U.S. added ~1.5m households for the second year in a row, "which sets up the wireline video and broadband ecosystems well in 2019," says the analyst. Altice USA (ATUS) and Charter Communications (CHTR) are both on the JPMorgan's Analyst Focus List, and Comcast (CMCSA) is Cusick's favorite mega-cap service provider. The analyst is "wary" of the multiple of Underweight-rated Cable One (CABO), but admits its operational momentum seems strong.
03/29/19
03/29/19
UPGRADE
Target $35

Buy
Viacom upgraded to Buy at Loop Capital on de-risked AT&T loss
As previously reported, Loop Capital analyst Alan Gould upgraded Viacom (VIAB) to Buy from Hold with a price target of $35. The analyst cites the company's loss of its biggest distributor AT&T (T) having been de-risked which, he believes, raises the likelihood of a Viacom merger with CBS (CBS). Gould adds that despite the renewed distribution deal with AT&T, investors can accumulate shares at a lower price than a few weeks ago, resulting in a "positive risk-reward" for Viacom.
SPOT Spotify
$139.53

1.88 (1.37%)

02/07/19
RBCM
02/07/19
NO CHANGE
Target $190
RBCM
Outperform
Spotify price target lowered to $190 from $200 at RBC Capital
RBC Capital analyst Mark Mahaney lowered his price target on Spotify after its Q4 earnings, saying that while the quarter was "in-line to modestly above" consensus, the outlook for Q1 missed in terms of gross margins and operating losses. The analyst keeps his Outperform rating on Spotify, attributing the misses "almost entirely to pending acquisitions & investments in Podcasts", which he sees as a "smart strategic direction".
03/29/19
FBCO
03/29/19
INITIATION
Target $120
FBCO
Underperform
Spotify initiated with an Underperform at Credit Suisse
Credit Suisse analyst Brian Russo initiated Spotify with an Underperform rating and $120 price target. In a research note to investors, Russo says that while he expects significant subscriber and revenue growth, he believes consensus multiyear expectations for its subscribers and margins are too high and sees risk as ongoing battles over content costs support concerns around Spotify's profit potential.
03/21/19
RHCO
03/21/19
NO CHANGE
RHCO
Apple event may be negative for Netflix, positive for Lions Gate, says SunTrust
SunTrust analyst Matthew Thornton previews Apple's (AAPL) media event scheduled for March 25th, saying the company is likely to unveil a Video Service. The analyst believes that an Apple OTT service could be a positive for Lions Gate (LGF.B) given the participation of the Starz networks but negative for Netflix (NFLX) "if Apple can offer compelling content bundles at compelling prices with a compelling UI and ubiquitous access". Thornton adds that Apple's bundling of its Music with video subscriptions and news subscriptions may be a negative for Spotify (SPOT) and a "modest incremental negative" for Roku (ROKU) if Apple's service app is not on its service.
03/13/19
KEYB
03/13/19
NO CHANGE
KEYB
Sector Weight
KeyBanc says Spotify complaint a risk to Apple given significant merit of claim
After Spotify (SPOT) filed a complaint with the European Commission claiming Apple (AAPL) has implemented anti-competitive practices in App Store policies, KeyBanc analyst Andy Hargreaves said he believe Spotify's claim has "significant merit" and are likely to carry significant weight when presented to the EC's competition committee. He sees the most significant financial risk to Apple coming from a forced requirement to allow first party and other third party payment processing from within apps, which Hargreaves said would likely drive the current 30% rate Apple collects "down substantially." The complaint also creates brand risk in addition to financial risk, according to the analyst, who keeps a Sector Weight rating on Apple shares.
SAM Boston Beer
$266.90

0.89 (0.33%)

04/05/19
04/05/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Market Perform from Outperform at Wells Fargo with analyst Aaron Rakers saying the shares, after rallying 19% year-to-date, reflect a more balanced risk/reward. 2. Boston Beer (SAM) downgraded to Sell from Neutral at Goldman Sachs with analyst Judy Hong saying she sees headwinds in 2019 as competition intensifies and the company is "unlikely to repeat its innovation success again this year." 3. Ford (F) downgraded to Reduce from Neutral at Nomura Instinet with analyst Anindya Das saying Ford's higher share of the U.K. auto market compared to the rest of Europe makes it more susceptible to Brexit risks. 4. Constellation Brands (STZ) downgraded to Hold from Buy at Deutsche Bank. 5. International Paper (IP) downgraded to Sector Perform from Outperform at RBC Capital with analyst Paul Quinn saying while International Paper is a "great company," investors have increased scrutiny on the containerboard market due to the "softening demand and fears of incremental capacity coming online" as year-to-date shipment growth slowed to 0.8% from 1.5% in 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/21/19
02/21/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Canon (CAJ) upgraded to Neutral from Sell at Goldman Sachs with analyst Satoru Ogawa citing the company's cost cuts and less downside to his price target. 2. Boston Beer (SAM) upgraded to Neutral from Underperform at Macquarie with analyst Caroline Levy saying she forcasts the company's non-beer portfolio that includes Twisted Tea,Truly and Angry Orchard brands to help contribute to its double-digit revenue growth in 2019. 3. U.S. Steel (X) upgraded to Buy from Hold at Berenberg with analyst Paretosh Misra citing an increase in EBITDA estimates from higher pricing. 4. FARO Technologies upgraded to Buy from Hold at Gabelli with analyst Hendi Susanto citing an attractive valuation and positive view on the company's "growth execution and initiatives toward operating margin improvement in 2019." 5. Aaron's (AAN) upgraded to Buy from Neutral at Northcoast with analyst Tim Vierengel saying the Best Buy (BBY) partnership is a key point of growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/19
GSCO
04/05/19
DOWNGRADE
Target $245
GSCO
Sell
Goldman downgrades Boston Beer to Sell, prefers Constellation Brands
Goldman Sachs analyst Judy Hong downgraded Boston Beer (SAM) to Sell from Neutral and lowered her 12-month price target for the shares to $245 from $270. The analyst sees headwinds in 2019 as competition intensifies and the company is "unlikely to repeat its innovation success again this year." She lowered her 2019 and 2020 depletions forecasts for Boston Beer primarily to reflect slower growth in Twisted Tea as well as the fading contribution from Rose Cider. Multiple compression as depletion growth slows in the coming months will drive downside to the stock, Hong tells investors in a research note. The analyst favors Constellation Brands (STZ) within her Alcoholic Beverage coverage.
04/04/19
GSCO
04/04/19
DOWNGRADE
GSCO
Sell
Boston Beer downgraded to Sell from Neutral at Goldman Sachs
PINS Pinterest
$24.46

(0.00%)

04/15/19
04/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pinterest (PINS) initiated with a Neutral at DA Davidson. 2. Five Below (FIVE) initiated with a Buy at BofA/Merrill. 3. Levi Strauss (LEVI) initiated with an Outperform at Telsey Advisory, an Overweight at JPMorgan, a Buy at Citi and Guggenheim, an Equal Weight at Morgan Stanley, and a Neutral at Goldman Sachs and BofA/Merrill. 4. Tocagen (TOCA) initiated with a Market Perform at SVB Leerink. 5. Alcon (ALC) initiated with a Buy at Jefferies, while Allergan (AGN) was initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/15/19
DADA
04/15/19
INITIATION
Target $16
DADA
Neutral
Pinterest initiated with a Neutral at DA Davidson
DA Davidson analyst Tom Forte initiated Pinterest with a Neutral rating and a price target of $16. The analyst says the company offers consumers an "impressive visual-based discovery platform for merchandise" and advertisers "a large and growing global base of consumers with purchase intent" - a combination that he believes will "translate into long-term sales and profitability growth." However, Forte also sees the valuation for Pinterest already reflecting his favorable view of the company's growth prospects. The analyst adds that the potential catalysts for Pinterest stock to trade higher in the next 12 months include "product improvements for advertisers, efforts to drive international usage and monetization, and expansion into new content verticals."
04/15/19
DADA
04/15/19
INITIATION
DADA
Neutral
Pinterest initiated with a Neutral at DA Davidson
04/09/19
ATLE
04/09/19
INITIATION
Target $23
ATLE
Overweight
Atlantic bullish on Pinterest pre-IPO, calls valuation 'not challenging'
Atlantic Equities analyst James Cordwell earlier today initiated coverage of upcoming initial public offering Pinterest (PINS) with an Overweight rating and $23 price target. The company's 75M share IPO is expected to price between $15 and $17 per share. Pinterest's "unique and broadly appealing" proposition, which offers consumers the ability to view and collate visual recommendations, will enable "ongoing robust" user growth, Cordwell told investors in a research note. Further, the analyst expects "significant" monetization upside due to Pinterest's higher purchasing intent of the user base along with a lower current average revenue per user than other advertising-supported platform. Pinterest offers an attractive way to "diversify online advertising exposure" with non-GAAP profitability coming this year 2019 and a "not challenging" valuation, contends Cordwell.

TODAY'S FREE FLY STORIES

GE

General Electric

$10.04

-0.2 (-1.95%)

21:05
06/17/19
06/17
21:05
06/17/19
21:05
Periodicals
General Electric to cut another 450 jobs in Switzerland, Reuters says »

General Electric will lay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$86.25

-1.52 (-1.73%)

20:00
06/17/19
06/17
20:00
06/17/19
20:00
Hot Stocks
Arthur J. Gallagher acquires P2 Group, terms not stated »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

AGLNF

AGL Energy

$0.00

(0.00%)

19:28
06/17/19
06/17
19:28
06/17/19
19:28
Upgrade
AGL Energy rating change at Macquarie »

AGL Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.27

0.03 (0.36%)

, RUN

Sunrun

$17.09

0.64 (3.89%)

19:02
06/17/19
06/17
19:02
06/17/19
19:02
Upgrade
SunPower, Sunrun, SolarEdge rating change at Goldman Sachs »

SunPower, Sunrun upgraded…

SPWR

SunPower

$8.27

0.03 (0.36%)

RUN

Sunrun

$17.09

0.64 (3.89%)

SEDG

SolarEdge

$56.58

0.09 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

, PHAS

PhaseBio

$12.25

0.74 (6.43%)

18:48
06/17/19
06/17
18:48
06/17/19
18:48
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: MoneyGram (MGI)…

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

PHAS

PhaseBio

$12.25

0.74 (6.43%)

SPWR

SunPower

$8.27

0.03 (0.36%)

RUN

Sunrun

$17.09

0.64 (3.89%)

STLD

Steel Dynamics

$26.23

-0.19 (-0.72%)

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

RMTI

Rockwell Medical

$4.39

0.2 (4.77%)

CALA

Calithera Biosciences

$5.87

0.64 (12.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 18

    Jun

  • 19

    Jun

AAPL

Apple

$193.90

1.06 (0.55%)

18:44
06/17/19
06/17
18:44
06/17/19
18:44
Periodicals
Apple's tvOS 13 beta 2 includes Picture-in-Picture support, 9to5Mac reports »

Apple's tvOS 13 beta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$56.58

0.09 (0.16%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
SolarEdge rating change at Goldman Sachs »

SolarEdge upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUN

Sunrun

$17.09

0.64 (3.89%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
Sunrun rating change at Goldman Sachs »

Sunrun upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.27

0.03 (0.36%)

18:33
06/17/19
06/17
18:33
06/17/19
18:33
Upgrade
SunPower rating change at Goldman Sachs »

SunPower upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLSFY

Bluescope Steel

$0.00

(0.00%)

18:32
06/17/19
06/17
18:32
06/17/19
18:32
Hot Stocks
Bluescope Steel cuts FY19 EBIT growth view to up 6% from up 10% »

BlueScope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$147.54

-1.25 (-0.84%)

18:24
06/17/19
06/17
18:24
06/17/19
18:24
Hot Stocks
International Flavors CEO: We have planned for Brexit and China is benign for us »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.63

-0.65 (-1.12%)

18:24
06/17/19
06/17
18:24
06/17/19
18:24
Periodicals
Senator aims to bar Huawei from seeking damages in patent courts, Reuters says »

U.S. Senator Marco Rubio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:12
06/17/19
06/17
18:12
06/17/19
18:12
Hot Stocks
Breaking Hot Stocks news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$39.00

1.46 (3.89%)

18:04
06/17/19
06/17
18:04
06/17/19
18:04
Hot Stocks
Dish launches OnTech Smart Services »

Dish announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$32.30

-0.06 (-0.19%)

18:03
06/17/19
06/17
18:03
06/17/19
18:03
Hot Stocks
AT&T wins 24 GHz spectrum following FCC Auction 102 »

AT&T is the winning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:02
06/17/19
06/17
18:02
06/17/19
18:02
Syndicate
Biohaven Pharmaceutical offers to sell $300M in common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSM

Versum Materials

$51.42

0.01 (0.02%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

18:01
06/17/19
06/17
18:01
06/17/19
18:01
Hot Stocks
Versum Materials shareholders approve merger with Merck KGaA »

Versum Materials (VSM)…

VSM

Versum Materials

$51.42

0.01 (0.02%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

VLO

Valero

$76.93

0.19 (0.25%)

18:00
06/17/19
06/17
18:00
06/17/19
18:00
Periodicals
Valero restarting Port Arthur, Texas refinery hydrocracker, Reuters says »

Valero is restarting the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

VLO

Valero

$76.93

0.19 (0.25%)

17:59
06/17/19
06/17
17:59
06/17/19
17:59
Periodicals
Valero restarting Meraux, Louisiana refinery hydrocracker, Reuters says »

Valero is restarting the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

17:44
06/17/19
06/17
17:44
06/17/19
17:44
Hot Stocks
MoneyGram spikes almost 140% after blockchain company Ripple investment »

Money transfer company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

JKS

JinkoSolar

$22.59

-2.08 (-8.43%)

17:37
06/17/19
06/17
17:37
06/17/19
17:37
Downgrade
JinkoSolar rating change at UBS »

JinkoSolar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

FCEL

FuelCell

$0.33

-0.0231 (-6.56%)

17:26
06/17/19
06/17
17:26
06/17/19
17:26
Earnings
FuelCell reports Q2 ($2.06), consensus ($2.24) »

Reports Q2 revenue $9.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMTI

Rockwell Medical

$4.39

0.2 (4.77%)

17:25
06/17/19
06/17
17:25
06/17/19
17:25
Hot Stocks
Breaking Hot Stocks news story on Rockwell Medical »

Rockwell Medical down 21%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

VRS

Verso

$17.91

-0.24 (-1.32%)

17:21
06/17/19
06/17
17:21
06/17/19
17:21
Hot Stocks
Verso adopts limited duration stockholder rights plan »

Verso announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHVKF

China Vanke Co

$0.00

(0.00%)

17:19
06/17/19
06/17
17:19
06/17/19
17:19
Downgrade
China Vanke Co rating change at Morgan Stanley »

China Vanke Co downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.